• Forge and manage strategic partnerships. • Identify, evaluate, and cultivate high-impact relationships with leading academic investigators, clinical networks, professional societies, and patient advocacy groups within the hypertension and broader CRM community. • Build collaborative frameworks that expand scientific exchange, facilitate data generation, and amplify Mineralys’ visibility in the field. • Design and implement an integrated engagement roadmap aligned with Medical Affairs pillars, Scientific Communication Platform, and corporate objectives. • Partner closely with field medical, scientific communications, HEOR, and clinical development teams to ensure coordinated and compliant interactions. • Lead external collaborations with Key Opinion Leaders (KOLs), digital opinion leaders (DOLs), and academic consortia to deepen understanding of aldosterone-driven disease mechanisms and treatment paradigms. • Integrate scientific and clinical insights into medical strategies, field guidance, and future development planning. • Serve as the Medical Affairs lead for guideline and compendia inclusion strategy, aligning internal evidence generation, publication planning, and external KOL engagement to meet evidence thresholds for consideration. • Build and sustain strategic alliances with key guideline committees, scientific societies, and evidence-based medicine organizations to advocate for inclusion of lorundrostat-related data. • Design, plan, and execute compliant scientific advisory board meetings (virtual and in-person) to obtain actionable insights that inform Medical Affairs strategy, evidence generation, and external engagement priorities.